Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Haizheng Pharma: Wholly-owned subsidiary Hanhui Pharma's Haibomaibu Atorvastatin Calcium Tablets Approved for Clinical Trials
Haizheng Pharmaceutical announced that its wholly-owned subsidiary Hanhui Pharmaceutical Co., Ltd. has received the “Drug Clinical Trial Approval Notice” from the National Medical Products Administration for Haibo Mebavastatin Calcium Tablets (10mg/20mg). The indication for Haibo Mebavastatin Calcium Tablets is for the treatment of adult patients with primary hypercholesterolemia or mixed hyperlipidemia who are unable to achieve target LDL-C levels with statin monotherapy, based on dietary control.